NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LncTAC Biotechnology Co., Ltd.

LncTAC Biotechnology Co., Ltd.

Private
ChengduHealthcare & Life Scienceshttps://lnctac.com/

Last Round

Series A

Jun 26, 2026

Total Funding Raised

$44.25M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

LncTAC Biotechnology Co., Ltd. is a biotechnology company that develops lncRNA-based therapeutic drugs and delivery technology platforms for oncology, central nervous system disorders, and dermatology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

nucleic acid therapeuticslong non-coding RNAlncRNARNA therapeuticsdrug discovery platformlncTACtargeted chimera technologyUNASTnucleic acid deliveryRNA medicineextrahepatic deliveryundruggable targetsbiotech R&Dprecision medicinedrug out-licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LncTAC Biotechnology Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

LncTAC Biotechnology Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

LncTAC Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 26, 2026
VC RoundOct 26, 2023

LncTAC Biotechnology Co., Ltd. Investors

Notable investors and investment history

LncTAC Biotechnology Co., Ltd. investors
InvestorRounds
Lapam CapitalSeries A
Legend CapitalSeries A, VC Round
Sunshine Riverhead Capital Investment Management Co., Ltd.Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 26, 2026

    $44.25M round led by Lapam Capital.

LncTAC Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LncTAC Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LncTAC Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu
Year Founded2021
Last FundingJun 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.